CIK: 0001281446 · Show all filings
Period: Q3 2016 (← Previous) (Next →)
Filing Date: Nov 14, 2016
Total Value ($000): $392,073 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| VNDA | VANDA PHARMACEUTICALS INC. CMN | 2,706,134 | $45,030 | 11.5% | $10.50 | +28.3% | COM | 921659108 |
| — | ADAMAS PHARMACEUTICALS INC CMN | 2,601,351 | $42,688 | 10.9% | $18.31 | — | COM | 00548A106 |
| — | SYNERGY PHARMACEUTICALS INC CMN | 6,422,232 | $35,386 | 9.0% | $4.49 | — | COM | 871639308 |
| — | ZOGENIX INC CMN | 2,440,959 | $27,900 | 7.1% | $11.56 | — | COM | 98978L204 |
| — | FOAMIX PHARMACEUTICALS LIMITED CMN | 2,769,425 | $25,645 | 6.5% | $8.97 | — | COM | M46135105 |
| — | DERMIRA INC CMN | 679,403 | $22,977 | 5.9% | $29.25 | — | COM | 24983L104 |
| — | IGNYTA INC CMN | 3,475,227 | $21,859 | 5.6% | $5.59 | — | COM | 451731103 |
| ENTA | ENANTA PHARMACEUTICALS INC CMN | 790,000 | $21,022 | 5.4% | $25.23 | -8.0% | COM | 29251M106 |
| NBIX | NEUROCRINE BIOSCIENCES INC CMN | 394,080 | $19,956 | 5.1% | $41.64 | +19.6% | COM | 64125C109 |
| — | AVEXIS INC CMN | 381,095 | $15,703 | 4.0% | $41.20 | — | COM | 05366U100 |
| — | MERRIMACK PHARMACEUTICALS INC CMN | 2,442,159 | $15,508 | 4.0% | $6.35 | — | COM | 590328100 |
| — | COLUCID PHARMACEUTICALS INC CMN | 400,000 | $15,260 | 3.9% | $38.15 | — | COM | 19716T101 |
| — | BOVIE MEDICAL CORPORATION CMN | 2,680,000 | $13,963 | 3.6% | $2.72 | — | COM | 10211F100 |
| — | SAGE THERAPEUTICS, INC CMN | 264,893 | $12,198 | 3.1% | $30.13 | — | COM | 78667J108 |
| — | CONNECTURE INC | 4,127,232 | $7,759 | 2.0% | $9.01 | — | COM | 20786J106 |
| — | ARADIGM CORP CMN | 1,002,962 | $6,900 | 1.8% | $8.85 | — | COM | 038505400 |
| — | OCERA THERAPEUTICS INC CMN CLASS | 1,963,777 | $5,184 | 1.3% | $6.20 | — | COM | 67552A108 |
| — | DBV TECHNOLOGIES SA SPONSORED ADR CMN | 131,452 | $4,776 | 1.2% | $36.33 | — | COM | 23306J101 |
| — | SUNESIS PHARMACEUTICALS INC CMN | 1,063,573 | $4,648 | 1.2% | $4.37 | — | COM | 867328700 |
| — | ALIMERA SCIENCES CMN | 2,637,969 | $3,931 | 1.0% | $1.49 | — | COM | 016259103 |
| BCRX | PUT/BCRX @ 5 EXP 03/17/2017 | 725,000 | $3,197 | 0.8% | — | — | Put | 09058V103 |
| — | PUT/GWPH @ 95 EXP 10/21/2016 | 23,800 | $3,159 | 0.8% | — | — | Put | 36197T103 |
| — | DIPEXIUM PHARMACEUTICALS INC CMN | 178,930 | $2,594 | 0.7% | $12.24 | — | COM | 25456J104 |
| — | TENAX THERAPEUTICS INC CMN | 1,108,593 | $2,568 | 0.7% | $3.93 | — | COM | 88032L100 |
| — | PDL BIOPHARMA INC CMN | 645,000 | $2,161 | 0.6% | $3.35 | — | COM | 69329Y104 |
| — | TETRAPHASE PHARMACEUTICALS INC CMN | 452,375 | $1,733 | 0.4% | $6.71 | — | COM | 88165N105 |
| — | CATABASIS PHARMACEUTICALS, INC CMN | 250,000 | $1,540 | 0.4% | $6.16 | — | COM | 14875P107 |
| — | MIRATI THERAPEUTICS INC CMN | 227,657 | $1,505 | 0.4% | $6.61 | — | COM | 60468T105 |
| — | SERES THERAPEUTICS, INC. CMN | 120,000 | $1,475 | 0.4% | $12.29 | — | COM | 81750R102 |
| — | PUT/MCRB @ 20 EXP 10/21/2016 | 120,000 | $1,475 | 0.4% | $12.29 | — | Put | 81750R102 |
| — | INOTEK PHARMACEUTICALS CORP CMN | 94,077 | $892 | 0.2% | $9.48 | — | COM | 45780V102 |
| — | CALL/NVAX @ 8 EXP 10/21/2016 | 409,200 | $851 | 0.2% | — | — | Call | 670002104 |
| — | STREAMLINE HEALTH SOLUTNS, INC CMN | 151,611 | $279 | 0.1% | $6.45 | — | COM | 86323X106 |
| ARDX | ARDELYX INC CMN | 15,000 | $194 | 0.0% | $9.95 | +5.3% | COM | 039697107 |
| — | CALL/OPHT @ 80 EXP 01/20/2017 | 3,400 | $157 | 0.0% | — | — | Call | 683745103 |